Vaxil Announces CEO ResignationWell Blig. You got what you asked for. Now what?
NESS-ZIONA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“ Vaxil ” or the “ Company ”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious diseases, today announces that Mr. David Goren has provided notice that he will be resigning as the Company's chief executive officer (“ CEO ”) to pursue other opportunities. The resignation will take effect on August 1, 2021 (the “ Effective Date ”). Mr. Goren has agreed that until the Effective Date, he will, in addition to continuing to fulfill his responsibilities as CEO, assist the Company's board of directors (" Board ") in their search for a new CEO, which has already commenced.
The Board wishes to thank Mr. Goren for his contributions to the Company over the past two and a half years, and wishes him success in his future endeavors.
Mr. Goren remains a director of the Company.